DoW Rare Cancers Idea Development Award
Defense Health Agency Contracting Activity - DHACA · Military Medical Research and Development (12.420)
Publié 17 juin 2026 · 41 jours restants
En clair
Résumé pas encore disponible en français ; affiché en anglais.
The US Defense Health Agency funds research ideas on rare cancers that show promise for high-impact findings and new research directions, with preliminary data required. The programme is open to any type of organisation based in the United States, with applications due by 18 November 2026.
Un résumé généré du texte du bailleur ; la formulation originale figure ci-dessous.
Résumé
Texte original du bailleur (anglais)
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation.
Distinctive Features:
The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research.
Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study.
Research should have high potential impact on rare cancers and the patient community.
Extrait de la page du bailleur. Le texte intégral, les annexes et les formulaires se trouvent dans l'appel original.
Qui peut candidater
- ONG / société civile
- Établissement universitaire ou de recherche
- Entreprise privée
- Organisme public
- Entreprise sociale ou coopérative
- Particulier
- Agence de l'ONU ou intergouvernementale
- Autre type de candidat
Éligibilité et conditions
Afficher le texte d'éligibilité de la source · Texte original du bailleur (anglais)
Applicant types: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"